NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

** HEALTH RESEARCH SHOWCASE THURSDAY 29 MAY 2025 **

News

You are here: Home > Cancer > New treatment for lung, liver and renal tumours

New treatment for lung, liver and renal tumours

27 November 2011 · Listed under Cancer

Doctors, surgeons and researchers from the Imaging Theme of the NIHR Biomedical Research Centre, Oxford are looking into the effectiveness of using ablation as another treatment option for lung, liver and renal tumours.

Microwave Ablation is used to treat small tumors by passing a needle-like probe inside the tumour. The microwaves released from the probe increase the temperature within tumour tissue that results in cell death.

Professor Fergus Gleeson and Dr Mark Anderson, consultant radiologists have been using the new system at the Oxford University Hospitals and believe it could substantially improve cancer care in some patients. They are also using high-tech scanners, in a clinical trial following ablation treatment, to ensure the cancer cells have been destroyed.

The team, based at the Churchill Hospital, have been working with Hampshire-based Microsulis Medical using their Acculis MTA system which can destroy tumours up to 4-5cms in size in six minutes.

Professor Gleeson said: “This is a fantastic development.  It will kill small tumours in minutes and we are examining how it can improve survival by reducing cancer mass in large tumours.

“We would like this to be more widely available to patients in the UK.  We believe it may potentially save thousands of lives each year.”

Read more…

← Ten years of collaboration brings new hope for patients
Research@Oxford – Improving Health →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at [email protected]

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre